Regional Discussion Group - June 24 - Latin America: TFR vs Dose Reduction

In the first of our Latin America Regional Discussion Groups for 2024 we debate whether TFR or dose reduction is the better pathway to stopping therapy.

Experts:
Dr Virginia Abello Polo
Center for Cancer Treatment and Research
Luis Carlos Sarmiento Angulo Foundation,
Bogota, Colombia

Professor Ehab Atallah
Hematologic Malignancies Division of
Hematology & Oncology,
Medical College of Wisconsin, USA

Dr M Soledad Undurraga Sutton
Clinica Universidad de Los Andes,
Santiago, Chile

Professor Tim Hughes
University of Adelaide
SA Health and Medical Research Institute
Adelaide, Australia

00:00 Welcome
02:10 Introduction
05:32 Dose reduction the best pathway to TFR
22:47 The Case in Favour of direct TFR
42:31 Rebuttals and replies
50:06 Audience discussion
02:10:01 Conclusion and thanks